A股異動 | 樂心醫療(300562.SZ)低位彈升5% 實際控制人擬增持不低於3000萬元
格隆匯2月5日丨此前連續下跌創近一年新低價的樂心醫療(300562.SZ)今日高開反彈,漲4.96%,報16.92元,總市值32.24億元。樂心醫療4日公吿,近日收到公司控股股東、實際控制人潘偉潮先生關於計劃增持公司股份的吿知函,基於對公司健康IoT和遠程健康管理業務持續高速增長的堅定信心,以及對公司股票投資價值的認同,潘偉潮先生計劃自本公吿之日起6個月內增持公司股份,本次增持金額不低於人民幣3,000萬元,增持價格不超過30元/股。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.